XML 40 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accum. Other Comp. Income (Loss)
Accum. Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2021   76,919,000        
Beginning balance at Dec. 31, 2021 $ 94,596 $ 77 $ 831,424 $ (907) $ (735,998)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)   2,373,000        
Issuance of restricted stock, net of shares withheld for taxes, and other (211) $ 2 (213)      
Issuance of common stock under ESPP (in shares)   583,000        
Issuance of common stock under ESPP 820 $ 1 819      
Exercise of stock options (in shares)   29,000        
Exercise of stock options 98   98      
Stock-based compensation expense 14,880   14,880      
Repurchase of common stock (in shares)           (422,000)
Repurchase of common stock (563)         $ (563)
Net Income (Loss) (190,098)       (190,098)  
Other comprehensive loss, net of tax (989)     (989)    
Ending balance (in shares) at Dec. 31, 2022   79,904,000        
Ending balance at Dec. 31, 2022 (81,467) $ 80 847,008 (1,896) (926,096) $ (563)
Treasury stock, ending balance (in shares) at Dec. 31, 2022           (422,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)   2,946,000        
Issuance of restricted stock, net of shares withheld for taxes, and other (116) $ 3 (119)      
Issuance of common stock under ESPP (in shares)   470,000        
Issuance of common stock under ESPP 723   723      
Exercise of stock options (in shares)   44,000        
Exercise of stock options 81   81      
Stock-based compensation expense 13,123   13,123      
Repurchase of common stock (in shares)           (2,710,000)
Repurchase of common stock (5,414)         $ (5,414)
Net Income (Loss) (74,656)       (74,656)  
Other comprehensive loss, net of tax $ (325)     (325)    
Ending balance (in shares) at Dec. 31, 2023 80,232,000 83,364,000        
Ending balance at Dec. 31, 2023 $ (148,051) $ 83 860,816 (2,221) (1,000,752) $ (5,977)
Treasury stock, ending balance (in shares) at Dec. 31, 2023 3,132,000         (3,132,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of redeemable preferred stock (shares)   92,931,000        
Conversion of redeemable preferred stock $ 311,253 $ 93 357,174   (46,014)  
Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)   5,519,000        
Issuance of restricted stock, net of shares withheld for taxes, and other (459) $ 5 (464)      
Issuance of common stock under ESPP (in shares)   516,000        
Issuance of common stock under ESPP $ 918 $ 1 917      
Exercise of stock options (in shares) 715,000 575,000        
Exercise of stock options $ 1,152 $ 1 1,151      
Stock-based compensation expense 31,732   31,732      
Repurchase of common stock (in shares)           (15,448,000)
Repurchase of common stock (40,490)         $ (40,490)
Common stock relinquished in litigation settlement 1,009   1,009      
Common stock issued as consideration in business combinations (in shares) [1]   213,205,000        
Common stock issued as consideration in business combinations [1] 450,097 $ 213 449,884      
Net Income (Loss) (138,885)       (138,885)  
Other comprehensive loss, net of tax $ 3,446     3,446    
Ending balance (in shares) at Dec. 31, 2024 377,530,000 396,110,000        
Ending balance at Dec. 31, 2024 $ 471,722 $ 396 $ 1,702,219 $ 1,225 $ (1,185,651) $ (46,467)
Treasury stock, ending balance (in shares) at Dec. 31, 2024 18,580,000         (18,580,000)
[1] Merger (as defined below) consideration included 26,367 shares of common stock that were issued to a related party. See Note 18, Related Parties.